MMRGlobal Announces Secure Storage for Medical Cannabis Users
April 24 2014 - 8:15AM
Marketwired
MMRGlobal Announces Secure Storage for Medical Cannabis Users
LOS ANGELES, CA--(Marketwired - Apr 24, 2014) - MMRGlobal, Inc.
(OTCQB: MMRF) ("MMR") today announced that its patented
MyMedicalRecords Personal Health Record (PHR) is now being sold in
medical cannabis dispensaries. The Company's wholly owned
subsidiary, MyMedicalRecords, Inc., launched its program of selling
PHRs through dispensaries after months of testing various marketing
and sales incentive programs. MyMedicalRecords also has plans to
license its patented PHR technologies to others in the cannabis
space who may be offering products that infringe on the Company's
MyMedicalRecords patents and other intellectual property.
Every password-protected MyMedicalRecords account includes four
MyEsafeDepositBox file folders with additional layers of security
that can be used to give medical cannabis patients a private and
safe place to store encrypted copies of physician recommendations
and/or prescriptions. These folders allow patients to protect their
sensitive medical information from unauthorized access or view.
MyMedicalRecords keeps a user's most personal, private information
pertaining to cannabis usage from employer and government
intrusiveness as well as any others who might inadvertently view
private medical records or cannabis recommendations in a home or
office file. This could be particularly damaging to patients who
use medical cannabis to navigate through significant health issues;
for example, glaucoma patients taking medical cannabis to better
manage the effects of reduced intraocular pressure, or patients
experiencing side effects from chemotherapy, as well as those who
are prescribed it for pain management from fibromyalgia or
non-specific neuropathy, among other conditions. Damages from
corporate intrusion into an employee's legitimate medical issues
can be partially avoided by using a secure MyMedicalRecords
PHR.
Another valuable feature of using a MyMedicalRecords PHR is the
ability for individuals to prove they indeed have a prescription by
carrying an encrypted copy in their MyMedicalRecords account on
their smartphone to have whenever and wherever it's needed
including to display to law enforcement officers should the need
arise. MMR has created a complete program for cannabis retailers
including customized point-of-sale displays with built-in systems
designed to incentivize employees and customers through frequent
purchase incentives, communicate and distribute newsletters, and
conduct market research. Try a MyMedicalRecords PHR for free at
www.mymedicalrecords.com.
MMRGlobal is a leading provider of Personal Health Records,
MyEsafeDepositBox storage solutions and MMRPro document management
and imaging systems for healthcare professionals. The use of Personal Health
Records is a key part of modernizing America's healthcare system
and the government is spending hundreds of millions of dollars in
education designed to empower patients to take greater control of
their health, using tools such as a PHR.
About MMRGlobal MMRGlobal, Inc., through its wholly-owned
operating subsidiary, MyMedicalRecords, Inc., provides secure and
easy-to-use online Personal Health Records ("PHRs") and electronic
safe deposit box storage solutions, serving consumers, healthcare
professionals, employers, insurance companies, financial
institutions, retail pharmacies, and professional organizations and
affinity groups. The MyMedicalRecords PHR enables individuals and
families to access their medical records and other important
documents, such as birth certificates, passports, insurance
policies and wills, anytime from anywhere using the Internet.
MyMedicalRecords is built on proprietary, patented technologies to
allow documents, images and voicemail messages to be transmitted
and stored in the system using a variety of methods, including fax,
phone, or file upload without relying on any specific electronic
medical record platform to populate a user's account. MMR's
professional offering, MMRPro, is designed to give physicians'
offices an easy and cost-effective solution to digitizing
paper-based medical records and sharing them with patients through
an integrated patient portal. Through its merger with Favrille,
Inc. in January 2009, MMR acquired intellectual property biotech
assets that include anti-CD20 antibodies and data and samples from
its FavId™/Specifid™ vaccine clinical trials for the treatment of
B-Cell Non-Hodgkin's lymphoma. To learn more about MMRGlobal, Inc.
visit www.mmrglobal.com. View demos and video tutorials of MMR's
products and services at www.mmrtheater.com. Follow us at
Facebook.com/MMRGlobal and Twitter.com/mmrglobal.
Forward-Looking Statements Any statements contained in this
press release that refer to future events or other non-historical
matters are forward-looking statements, and some can be identified
by the use of words (and their derivations) such as "need,"
"possibility," "offer," "development," "if," "negotiate," "when,"
"begun," "believe," "achieve," "will," "estimate," "expect,"
"maintain," "plan," and "continue." Actual outcomes and results of
operations and the timing of selected events may differ materially
from the results predicted, and any reported results should not be
considered as an indication of future performance. Such statements
are necessarily based on assumptions and estimates and are subject
to various risks and uncertainties, including those relating to the
possible invalidity of the underlying assumptions and estimates and
possible changes or developments in economic, business, industry,
market, legal and regulatory circumstances and conditions and
actions taken or omitted to be taken by third parties, including
customers, suppliers, business partners, potential licensees,
competitors and legislative, judicial and other governmental
authorities and officials. The information discussed in this
release is subject to various risks and uncertainties related to
the Company's business prospects, results of operations or
financial condition; the risk our products and services are not
adopted or viewed favorably by the healthcare community and
consumer retail markets; unexpected outcomes with respect to
intellectual property enforcement actions, claims of intellectual
property infringement and general intellectual property litigation;
our ability to maintain, develop, monetize and protect our patent
portfolio for both MMR's health IT and biotechnology intellectual
property assets in the U.S. and internationally; risks related to
the current uncertainty and instability in financial and lending
markets, including global economic uncertainties; marketing
promotions and campaigns; product integration in physician
practices and hospitals; timing and volume of sales and
installations; length of sales cycles and the installation process;
programs and initiatives; ability to establish and maintain
strategic relationships; competitive product offerings and
promotions; maintaining, developing and defending our intellectual
property rights; marketing and exploitation of our patent
portfolio; government laws and regulations and future changes in
tax legislation and initiatives in the healthcare industry; legal,
regulatory, and other circumstances and conditions in the cannabis
industry; and such other risks and uncertainties as detailed from
time to time in MMRGlobal, Inc.'s public filings with the U.S.
Securities and Exchange Commission. The Company is providing this
information as of the date of this release and, except as required
by applicable law, does not undertake any obligation to update any
forward-looking statements contained in this release as a result of
new information, future events or otherwise.
CONTACT: Michael Selsman Public Communications Co.
ms@publiccommunications.biz (310)
922-7033